Appraisal of Non-Cardiovascular Safety for Sodium–Glucose Co-Transporter 2 Inhibitors: A Systematic Review and Meta-Analysis of Placebo-Controlled Randomized Clinical Trials

Background: Whereas the cardiovascular safety of sodium-glucose co-transporter 2 (SGLT2) inhibitors has been well reported, there is limited data from controlled clinical trials regarding the non-cardiovascular safety. This was the focus of our study. Methods and Findings: We systematically searched...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Fang-Hong, Li, Hao, Shen, Long, Zhang, Zhen, Jiang, Yi-Hong, Hu, Yao-Min, Liu, Xiao-Yan, Gu, Zhi-Chun, Ma, Jing, Lin, Hou-Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764217/
https://www.ncbi.nlm.nih.gov/pubmed/31616297
http://dx.doi.org/10.3389/fphar.2019.01066

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764217/
https://www.ncbi.nlm.nih.gov/pubmed/31616297
http://dx.doi.org/10.3389/fphar.2019.01066

Ejemplares similares